Skip to main content
Log in

Threonine fuels brain tumor growth through a conserved tRNA modification

  • Research Briefing
  • Published:

From Nature Cancer

View current issue Submit your manuscript

A CRISPR dropout screen for tRNA regulators identified YRDC as the top essential gene in glioblastoma stem cells. Threonine acts as a substrate of YRDC to facilitate the N6-threonylcarbamoyladenosine (t6A) tRNA modification and shift translation toward mitosis-related genes with a codon bias. Our findings support targeting glioblastoma growth by a well-tolerated dietary therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Threonine- and YRDC- mediated t6A formation can be targeted by dietary treatment.

References

  1. Gimple, R. C., Yang, K., Halbert, M. E., Agnihotri, S. & Rich, J. N. Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity. Nat. Rev. Cancer 22, 497–514 (2022). A review article that provides a comprehensive overview of the biology of brain cancer stem cells.

    Article  CAS  PubMed  Google Scholar 

  2. Suzuki, T. The expanding world of tRNA modifications and their disease relevance. Nat. Rev. Mol. Cell Biol. 22, 375–392 (2021). A review article that presents tRNA modifications and their roles in human diseases.

    Article  CAS  PubMed  Google Scholar 

  3. Dedon, P. C. & Begley, T. J. Dysfunctional tRNA reprogramming and codon-biased translation in cancer. Trends Mol. Med. 28, 964–978 (2022). A review article that presents dysregulation of tRNA epitranscriptome and codon-biased translation in cancer.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Yuan, H. et al. Lysine catabolism reprograms tumour immunity through histone crotonylation. Nature 617, 818–826 (2023). In this previous study from our group, we used dietary lysine restriction to reshape the immune microenvironment of GBM.

    Article  CAS  PubMed  Google Scholar 

  5. Lin, H. et al. CO2-sensitive tRNA modification associated with human mitochondrial disease. Nat. Commun. 9, 1875 (2018). This paper reports that mitochondrial t6A formation is dynamically regulated by CO2/bicarbonate.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Wu, X. et al. Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogramming. Nat. Cancer https://doi.org/10.1038/s43018-024-00748-7 (2024).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Threonine fuels brain tumor growth through a conserved tRNA modification. Nat Cancer (2024). https://doi.org/10.1038/s43018-024-00750-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s43018-024-00750-z

  • Springer Nature America, Inc.

Navigation